A systematic review and meta‐analysis of the impact of lymphovascular invasion in bladder cancer transurethral resection specimens
Open Access
- 28 May 2018
- journal article
- review article
- Published by Wiley in BJU International
- Vol. 123 (1) , 11-21
Abstract
The aim of the present review was to assess the prognostic impact of lymphovascular invasion ( LVI ) in transurethral resection ( TUR ) of bladder cancer ( BC a) specimens on clinical outcomes. A systematic review and meta‐analysis of the available literature from the past 10 years was performed using MEDLINE , EMBASE and Cochrane library in August 2017. The protocol for this systematic review was registered on PROSPERO (Central Registration Depository: CRD 42018084876) and is available in full on the University of York website. Overall, 33 studies (including 6194 patients) evaluating the presence of LVI at TUR were retrieved. LVI was detected in 17.3% of TUR specimens. In 19 studies, including 2941 patients with ≤ cT 1 stage only, LVI was detected in 15% of specimens. In patients with ≤ cT 1 stage, LVI at TUR of the bladder tumour ( TURBT ) was a significant prognostic factor for disease recurrence (pooled hazard ratio [ HR ] 1.97, 95% CI : 1.47–2.62) and progression (pooled HR 2.95, 95% CI : 2.11–4.13), without heterogeneity ( I 2 = 0.0%, P = 0.84 and I 2 = 0.0%, P = 0.93, respectively). For patients with cT 1–2 disease, LVI was significantly associated with upstaging at time of radical cystectomy (pooled odds ratio 2.39, 95% CI : 1.45–3.96), with heterogeneity among studies ( I 2 = 53.6%, P = 0.044). LVI at TURBT is a robust prognostic factor of disease recurrence and progression in non‐muscle invasive BC a. Furthermore, LVI has a strong impact on upstaging in patients with organ‐confined disease. The assessment of LVI should be standardized, reported, and considered for inclusion in the TNM classification system, helping clinicians in decision‐making and patient counselling.Keywords
This publication has 58 references indexed in Scilit:
- Lymphovascular invasion is independently associated with bladder cancer recurrence and survival in patients with final stage T 1 disease and negative lymph nodes after radical cystectomyBJU International, 2012
- Accurate preoperative prediction of non‐organ‐confined bladder urothelial carcinoma at cystectomyBJU International, 2012
- Multivariate Analysis of the Prognostic Significance of Resection Weight after Transurethral Resection of Bladder Tumor for Non-Muscle-Invasive Bladder CancerKorean Journal of Urology, 2012
- Clinical Predictive Factors of Poor Outcome in Patients With Stage pT0 Disease at Radical CystectomyJournal of Urology, 2011
- BRCA1 mRNA expression and outcome to neoadjuvant cisplatin-based chemotherapy in bladder cancerAnnals of Oncology, 2010
- The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and ElaborationPLOS Medicine, 2009
- Lymphovascular Invasion Predicts Clinical Outcomes in Patients With Node-Negative Upper Tract Urothelial CarcinomaJournal of Clinical Oncology, 2009
- P0 Stage at Radical Cystectomy for Bladder Cancer is Associated with Improved Outcome Independent of Traditional Clinical Risk FactorsEuropean Urology, 2007
- Measuring inconsistency in meta-analysesBMJ, 2003
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986